| Literature DB >> 22476962 |
P Bus1, P D Siersema, J W P M van Baal.
Abstract
BACKGROUND: Barrett's esophagus (BE) is a premalignant condition caused by chronic gastroesophageal reflux. BE patients have an increased risk of developing esophageal adenocarcinoma (EAC). As many aspects of this condition are still unknown, there is a need for in vitro models to study BE development. AIM: To review the literature on cell lines and incubation conditions for studying BE development.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22476962 PMCID: PMC3396334 DOI: 10.1007/s13402-012-0076-6
Source DB: PubMed Journal: Cell Oncol (Dordr) ISSN: 2211-3428 Impact factor: 6.730
Cell lines for studying pathogenetic mechanisms of Barrett’s esophagus
| Cell lines | Cell type |
|---|---|
| Het-1A | Squamous esophageal epithelial cell line |
| NES-B3T, NES-B10T | Cell line derived from squamous tissue from GERD patient with BE |
| NES-G2T, NES-G4T | Cell line derived from squamous tissue from GERD patient without BE |
| CP-D, BAR-T | Barrett’s epithelial cells |
| OE33, OE19, FLO-1, SKGT4 | Esophageal adenocarcinoma cell line |
Various cell lines used to study BE in an in vitro culture model along with the type of cell
Bile mixtures to study pathogenetic mechanisms of Barrett’s esophagus
| Article | Bile mix | Cell line | Incubation period | Findings | Conjugation status | Toxicity profile [ |
|---|---|---|---|---|---|---|
| Dvorak | 20 μM GCA + 20 μM TCA + 20 μM GDCA + 20 μM GCDCA + 20 μM DCA | Seg-1, Barrett’s cells and Het-1A | 10 min | No increase in oxidative stress | 80% | GCA, TCA, GDCA, GCDCA: +; DCA: - |
| Hao | 0.54 mM NGCA + 0.1 mM NTCA + 0.2 mM GCA + 0.1 mM NTCDCA | Seg-1 | 1 h | Cell number ↑; No change in cell viability | 100% | All: + |
| Jolly | NGCA + GCA + NTCA + NTCDCA (250 μM and higher) | Het-1A | 3 h | Cell viability↓ | 100% | All: + |
| NGCA + GCA + NTCA + NTCDCA (500 μM and higher) | FLO-1 | 3 h | Cell viability↓ | 100% | All: + | |
| Liu | GCA + TCA + GCDCA + TCDCA + GDCA + TDCA (20:3:15:3:6:1) (400 μM) | Het-1A and Seg-1 | 3 * 10 min/day for 7 days | Increase in CDX2 mRNA | 100% | All: + |
| Huo | GCA, TCA, GCDCA, TCDCA, GDCA, TDCA (400 μM) (20:3:15:3:6:1) at pH 4 or 7.2 | NES-G2T, NES-G4T; NES-B3T, NES-B10T | 3 * 10 min/day for 7 days | Increase in CDX2 mRNA and protein in NES-B3T and NES-B10T at pH 4 and pH 7.2 | 100% | All: + |
| Van Roon | GCA + TCA + GCDCA + TCDCA + GDCA + TDCA (20:3:15:3:6:1) (120 μM) | Het-1A | 3 * 5 min/day for 3 days | Increase in MUC1 mRNA | 100% | All: + |
Various articles investigated the pathogenetic mechanisms of Barrett’s esophagus, along with the bile mixtures, cell lines, incubation periods and the observed effect on cell viability, cell growth, oxidative stress and CDX2 expression
GCA glycocholic acid, TCA taurocholic acid, GDCA glycodeoxycholic acid, GCDCA glycochenodeoxycholic acid, DCA deoxycholic acid, NGCA sodium glycocholic acid, NTCA sodium taurocholic acid, NTCDCA sodium taurochenodeoxycholic acid. NES-G2T and NES-G4T, squamous esophageal epithelium cell line from GERD patients without BE; NES-B3T and NES-B10T, esophageal epithelium cell line from GERD patients with BE. CDX2, caudal type homeobox transcription factor 2
Toxicity profile: +, no effect or increased cell viability in bile salt toxicity test of Het-1A cells; -, decrease in cell viability below 50%
Bile salts at acidic pH to study pathogenetic mechanisms of Barrett’s esophagus
| Article | Cell line | Bile | pH | Incubation period | Findings | Conjugation status | Toxicity profile [ |
|---|---|---|---|---|---|---|---|
| Feagins | BAR-T cells | 200 μM GCDCA | 3, 4, 5 | 3 min | ROS levels increased | 100% | + |
| NES-B3T NES-G2T | 200 μM GCDCA | 4 | 3 min | ROS levels increased | 100% | + | |
| Dvorak | Seg-1 Het-1A | 100 μM bile mix (GCA + TCA + GDCA + GCDCA + DCA) | 4 | 10 min | Oxidative DNA damage | 80% | GCA, TCA, GDCA, GCDCA: +; DCA: - |
| Jolly | Het-1A FLO-1 | 1, 10, 100 μM bile mix (NGCA + GCA + NTCA + NTCDCA) | 4.5 | 15 min | DNA damage | 100% | All: + |
| Jenkins | OE33 | 100 μM – 200 μM DCA | 5.5 | 1 h | Increase in micronuclei | 0% | - |
| OE33 | 100 μM – 400 μM DCA | 6 | 1 h | Increase in micronuclei | 0% | - | |
| Liu | Het-1A SEG-1 | 400 μM bile mix (GCA + TCA + GCDCA + TCDCA + GDCA + TDCA (20:3:15:3:6:1)) | 4 | 3 * 10 min/day for 7 days | Increase in CDX2 mRNA | 100% | All: + |
| Huo | NES-G2T, NES-G4T; NES-B3T, NES-B10T | GCA, TCA, GCDCA, TCDCA, GDCA, TDCA (400 μM) (20:3:15:3:6:1) | 4 | 3 * 10 min/day for 7 days | Increase in CDX2 mRNA and protein in NES-B3T and NES-B10T | 100% | All: + |
| Goldman | Het-1A | 200 μM bile mix (GCA + TCA + GDCA + GCDCA + DCA) | 5.5 | Initially 10 min/ once or twice a week; built up till 120 min. | Increase in villin, CDX2, CK8/18, COX2 expression and IL-6 secretion | 80% | GCA, TCA, GDCA, GCDCA: +; DCA: - |
An overview of the articles studying the effect of acid and bile on the expression pattern and behaviour of esophageal cell lines
NES-B3T esophageal epithelium cell line from GERD patients with BE, NES-G2T squamous esophageal epithelium cell line from GERD patients without BE, GCDCA glycochenodeoxycholic acid, ROS reactive oxygen species, GCA glycocholic acid, TCA taurocholic acid, GDCA glycodeoxycholic acid, DCA deoxycholic acid, NGCA sodium glycocholic acid, NTCA sodium taurocholic acid, NTCDCA sodium taurochenodeoxycholic acid, CDX2 caudal type homeobox transcription factor 2. CK cytokeratin, COX2 cyclo-oxygenase-2, IL-6 Interleukin-6, Toxicity profile: +, no effect or increased cell viability in bile salt toxicity test of Het-1A cells; -, decrease in cell viability below 50%
The effect of the different durations of bile salt and/or acid incubations on the behaviour of the cell lines
| Time (min) | Squamous esophageal epithelial cells (Het-1A) | Barrett’s epithelial cells (BAR-T) | Adenocarcinoma cells (Seg-1, FLO-1, OE33, OE21) |
|---|---|---|---|
| 1 | pH 2, pH 4 → oxidative stress [ | pH 2 → oxidative stress [ | |
| 3 | 200 μM GCA at pH 4 → oxidative stress [ | ||
| 5 | 50 μM CDCA → cell proliferation ↑ [ | 50 – 100 μM TCA at pH 3-4.5 → ERK and p38 activation [ | |
| 10 | 100 μM bile mix at pH 4 → oxidative stress [ | ||
| 100 μM DCA at pH 5 → CDX2, VEGF ↑ [ | |||
| 15 | 100 μM bile mix at pH 4.5 → | 100 μM bile mix at pH 4.5 → DNA damage [ | |
| DNA damage [ | pH 3.5 → no change in cell proliferation [ | ||
| 20 | pH 3.5 → no change in cell proliferation [ | ||
| 50–1000 μM GCDCA → cell proliferation↑ [ |
An overview of the changes measured upon one short exposure to bile salts and/or acid
GCA glycocholic acid, CDCA chenodeoxycholic acid, TCA taurocholic acid, DCA deoxycholic acid, CDX2 caudal type homeobox transcription factor 2, VEGF vascular endothelial growth factor, GCDCA glycochenodeoxycholic acid
The effect of the different durations of bile salt and/or acid incubations on the behaviour of the cell lines
| Time (hrs) | Squamous esophageal epithelial cells (Het-1A) | Adenocarcinoma cells (Seg-1, FLO-1, OE33, SKGT4) |
|---|---|---|
| 1 | 940 μM bile mix → cell proliferation ↑ [ | |
| 100 or 200 μM DCA → DNA damage ↑ [ | ||
| pH 4 → NF-κB activity ↑ [ | ||
| pH 6-7 → EGR1 mRNA ↑ [ | ||
| 2 | 300 μM DCA → NF-κB activity ↑ [ | |
| 3 | 250 μM bile mix → cell viability ↓ [ | 500 μM bile mix → cell viability ↓ [ |
| 4 | 1000 μM DCA → CDX2, MUC2 ↑ [ | |
| 300 μM DCA → COX2 ↑ [ | ||
| 300 μM DCA → IL-8, IκB ↑ [ | ||
| 8 | 1000 μM DCA → MUC2, CDX2 ↑ [ | 300 μM DCA → MUC2, CDX2 ↑ [ |
| 18 | 50, 100 or 300 μM DCA, CDCA or TCA → NF-κB and MUC2 ↑ [ | |
| 24 | 200, 500 μM CA, 500 μM GCA or 1000 μM DCA → CDX2 ↑ [ | 1000 μM DCA → CDX2, MUC2 ↑ [ |
| 50, 100, 200 μM DCA → oxidative stress and micronuclei ↑ [ | ||
| 500 μM TCA, 1000 μM TDCA, 500 μM TCDCA, 500 μM GCA or 50 μM DCA → MUC1 ↑ [ | ||
| 100 μM DCA or CDCA with/without pH 4 → c-myc ↑ [ | ||
| 100 μM DCA → CDX2, VEGF ↑ [ | ||
| 48 | 100 μM CDCA → IL-6 secretion ↑ [ |
An overview of the changes measured upon one longer exposure to bile salts and/or acid
DCA deoxycholic acid, NF-κB Nuclear Factor- κB, EGR1 early growth response gene 1, CDX2 caudal type homeobox transcription factor 2, MUC2 mucin 2, GCA glycocholic acid, CA cholic acid. COX2 cyclooxygensase-2, IL-8 Interleukin-8, CDCA chenodeoxycholic acid, TCA taurocholic acid, TDCA taurodeoxycholic acid, TCDCA taurochenodeoxycholic acid, GCA glycocholic acid, MUC1 mucin 1, VEGF vascular endothelial growth factor
In vivo and in vitro reflux episodes and their induced changes
| Barrett’s epithelium of BE patients | Squamous esophageal epithelial cell lines | Barrett’s cell lines | Esophageal adenocarcinoma cell lines | ||
|---|---|---|---|---|---|
| Exposure: | 181 μM bile mix[ | 1000 μM DCA | 200 μM GCDCA | 200 μM GCDCA at pH4 or 7.4 | 300 μM DCA |
| Incubation period: | Multiple reflux episodes with an average duration of 2.6 min [ | 8 h | 5 min | Multiple incubations of 5 min | 8 h |
| Upregulation of: | CDX2 | CDX2 [ | Cell proliferation ↑ [ | CK8, 18 [ | CDX2 [ |
| CK7, 20, 8, 18 | MUC2 [ | COX2 [ | MUC2 [ | ||
| COX2 | NF-κB [ | ||||
| MUC2 | |||||
| NF-κB | |||||
| Cell proliferation ↑ | |||||
The effect of bile and different incubation periods on the expression pattern and behaviour of esophageal cell lines and the changes on the expression in vivo
DCA deoxycholic acid, GCDCA glycochenodeoxycholic acid, CDX2 caudal type homeobox transcription factor 2, CK cytokeratin, COX2 cyclo-oxygenase 2, MUC2 mucin 2, NF-κB Nuclear Factor- κB